Ligand validation:5AJO

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 5AJO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AJO_A2G_A_1570	86%	58%	0.078	0.946	0.49	1.12	-	2	0	0	100%	0.9333
5AJO_A2G_A_1571	60%	60%	0.12	0.904	0.64	0.89	-	1	0	0	100%	0.9333
5AJP_A2G_B_17	94%	55%	0.069	0.969	0.56	1.16	-	1	0	0	100%	0.9333
2A2D_A2G_A_459	99%	12%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5L_A2G_b_201	99%	57%	0.047	0.984	0.74	0.89	-	1	0	0	100%	0.9333
5T5P_A2G_b_201	99%	26%	0.046	0.982	1.11	1.86	2	3	0	0	100%	0.9333
5T5J_A2G_a_201	99%	42%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333
8PN5_A2G_I_101	99%	28%	0.049	0.98	1.82	1.08	3	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.